Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations
Human blood contains cell-free DNA (cfDNA), with circulating tumor-derived DNAs (ctDNAs) widely used in cancer diagnosis and treatment. However, it is still difficult to efficiently and accurately identify and distinguish specific ctDNAs from normal cfDNA in cancer patient blood samples. In this stu...
Main Authors: | Xiaojun Liu, Jidong Lang, Shijun Li, Yuehua Wang, Lihong Peng, Weitao Wang, Yingmin Han, Cuixiao Qi, Lei Song, Shuangshuang Yang, Kaixin Zhang, Guoliang Zang, Hong Pei, Qingqing Lu, Yonggang Peng, Shuxue Xi, Weiwei Wang, Dawei Yuan, Pingping Bing, Liqian Zhou, Geng Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00147/full |
Similar Items
-
Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L)
by: Kazuko Sakai, et al.
Published: (2021-01-01) -
Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma
by: Qiong Li, et al.
Published: (2020-07-01) -
Urine- and Blood-Based Molecular Profiling of Human Prostate Cancer
by: Gang Chen, et al.
Published: (2022-03-01) -
Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients
by: Natalia Galant, et al.
Published: (2024-02-01) -
Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC
by: Jarrod T. Smith, BA, et al.
Published: (2021-03-01)